Golden Matrix (GMGI) 10-Q 5 Dec 19 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Oct. 31, 2019	Nov. 28, 2019
Document And Entity Information
Entity Registrant Name	Golden Matrix Group, Inc.
Entity Central Index Key	0001437925
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--07-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	true
Entity Current Reporting Status	Yes
Document Period End Date	Oct. 31, 2019
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2020
Entity Ex Transition Period	false
Entity Common Stock Shares Outstanding		2,845,318,757

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Oct. 31, 2019	Jul. 31, 2019
Cash and cash equivalents	$ 2,305,117	$ 1,731,095
Accounts receivable, net	482,834	264,558
Accounts receivable - related parties	587,466	1,009,397
Total current assets	3,375,417	3,005,050
Total assets	3,375,417	3,005,050
Accounts payable and accrued liabilities	34,191	41,104
Accounts payable - related parties	589,649	526,541
Advances from shareholders	1,000	1,000
Accrued interest	36,515	24,510
Settlement payable - related party	290,000	145,000
Convertible notes payable, net of discounts	30,000	30,000
Convertible notes payable, net- in default	10,000	10,000
Promissory note-related party	636,754	1,033,567
Derivative liabilities - note conversion feature	10,834	15,000
Total current Liabilities	1,638,943	1,826,722
Settlement payable - related party - long-term		145,000
Total non-current liabilities		145,000
Total liabilities	1,638,943	1,971,722
Common stock: $0.00001 par value, 6,000,000,000 shares authorized, 2,845,318,757 and 2,845,318,757 shares issued and outstanding, respectively	28,453	28,453
Additional paid-in capital	27,600,551	27,443,293
Accumulated other comprehensive loss	(683)	(683)
Accumulated deficit	(25,891,847)	(26,437,735)
Total shareholders' equity	1,736,474	1,033,328
Total liabilities and shareholders' equity	3,375,417	3,005,050
Preferred Stock Series A [Member]
Preferred stock value
Preferred Stock Series B [Member]
Preferred stock value

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Oct. 31, 2019	Jul. 31, 2019
Shareholders' equity
Common stock, shares par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	6,000,000,000	6,000,000,000
Common stock, shares issued	2,845,318,757	2,845,318,757
Common stock, shares outstanding	2,845,318,757	2,845,318,757
Preferred stock, shares par value	$ 0.00001
Preferred stock, shares authorized	20,000,000
Preferred Stock Series A [Member]
Shareholders' equity
Preferred stock, shares par value	$ 0.00001	$ 0.00001
Preferred stock, shares authorized	19,999,000	19,999,000
Preferred stock, shares outstanding	0	0
Preferred Stock Series B [Member]
Shareholders' equity
Preferred stock, shares par value	$ 0.00001	$ 0.00001
Preferred stock, shares authorized	1,000	1,000
Preferred stock, shares outstanding	1,000	1,000
Preferred stock, shares issued	1,000	1,000

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Oct. 31, 2019	Oct. 31, 2018
Consolidated Statements of Operations (Unaudited)
Revenues	$ 362,276	$ 633
Revenues-related party	519,569	638,062
Cost of goods sold	(32,193)	(69,524)
Gross profit	849,652	569,171
Costs and expenses:
G&A expense	128,332	78,930
G&A expense- related party	33,000	39,300
Compensation expense - Acquisition cost - related party		16,119
Professional fees	18,815	20,831
Amortization expenses	120,679	57,347
Total operating expenses	300,826	212,527
Income from operations	548,826	356,644
Other income (expense):
Interest expense	(16,390)	(7,792)
Interest earned	9,286
Gain (Loss) on extinguishment of debt		(106)
Gain (Loss) on derivative liability	4,166	(16,747)
Total other income (expense)	(2,938)	(24,645)
Net income (Loss)	$ 545,888	$ 331,999
Net earnings (loss) per common share - basic	$ 0	$ 0
Net earnings (loss) per common share diluted	$ 0	$ 0
Weighted average number of common shares outstanding - basic	2,845,318,757	2,739,971,213
Weighted average number of common shares outstanding -diluted	4,200,458,688	2,772,534,713

Consolidated Statement of Share

Consolidated Statement of Shareholders Equity (Unaudited) - USD ($)	Total	Preferred Stock - Series B [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Income ( Loss ) [Member]	Accumulated Deficit [Member]
Balance, shares at Jul. 31, 2018		1,000	2,622,904,757
Balance, Amount at Jul. 31, 2018	$ (1,341,303)		$ 26,229	$ 26,840,794	$ (683)	$ (28,207,643)
Net Income (Loss)	$ 331,999					331,999
Issuance of shares for convertible notes conversion-related party, Shares			209,414,000
Fair value of options/warrants issued for services	$ 126,871			126,871
Issuance of shares for convertible notes conversion-related party, Amount	$ 209,414		$ 2,094	207,320
Issuance of shares for services, Shares			3,000,000
Issuance of shares for settlement of convertible note - related party	$ 5,310			5,310
Issuance of shares for services, Amount	$ 2,100		$ 30	$ 2,070
Balance, shares at Oct. 31, 2018		1,000	2,835,318,757
Balance, Amount at Oct. 31, 2018	$ (665,609)		$ 28,353	$ 27,182,365	$ (683)	$ (27,875,644)
Balance, shares at Jul. 31, 2019		1,000	2,845,318,757
Balance, Amount at Jul. 31, 2019	$ 1,033,328		$ 28,453	$ 27,443,293	$ (683)	$ (26,437,735)
Net Income (Loss)	545,888					$ 545,888
Imputed interest	4,386			4,386
Fair value of options/warrants issued for services	$ 152,872			$ 152,872
Balance, shares at Oct. 31, 2019		1,000	2,845,318,757
Balance, Amount at Oct. 31, 2019	$ 1,736,474		$ 28,453	$ 27,600,551	$ (683)	$ (25,891,847)

Consolidated Statements of Cash

Consolidated Statements of Cash Flow (Unaudited) - USD ($)	3 Months Ended
	Oct. 31, 2019	Oct. 31, 2018
Consolidated Statements of Cash Flow (Unaudited)
Net income (loss)	$ 545,888	$ 331,999
Unrealized loss (gain) on derivative liabilities-note conversion feature	(4,166)	16,747
Fair value of stock option issued for services	32,193	126,871
Fair value of shares issued for services		2,100
Amortization expense	120,679	3,300
Loss on extinguishment of debt		106
Fair value loss on contingent liability-related party		16,119
Imputed Interest	4,386
Penalty on convertible notes payable		3,300
Penalty on promissory note - related party	1,500
(Increase) decrease in accounts receivable	(218,276)	(633)
(Increase) decrease in accounts receivable - related party	421,931	(296,274)
(Increase) decrease in Prepaid expense		1,000
(Decrease) increase in accounts payable and accrued liabilities	(6,913)	19,784
(Decrease) increase in accounts payable - related party	63,108	7,333
(Decrease) increase in accrued interest	12,005	4,494
Net cash provided by operating activities	972,335	234,246
Cash flows from financing activities:
Repayments on settlement payable		(102,420)
Repayments on promissory note	(398,313)
Net cash (used in) financing activities	(398,313)	(102,420)
Net increase in cash and cash equivalents	574,022	133,826
Cash and cash equivalents at beginning of year	1,731,095	446,581
Cash and cash equivalents at end of year	2,305,117	580,407
Supplemental disclosure of cash flow information:
Settlement of derivative liability		5,310
Common stock issued for conversion of debt		209,414
Debt discount from derivative liability		3,300
Settlement payable		$ 448,012

BASIS OF PRESENTATION AND ACCOU

BASIS OF PRESENTATION AND ACCOUNTING POLICIES	3 Months Ended
	Oct. 31, 2019
BASIS OF PRESENTATION AND ACCOUNTING POLICIES
NOTE 1 - BASIS OF PRESENTATION AND ACCOUNTING POLICIES	Golden Matrix Group, Inc. (“GMGI” or “Company”) was incorporated in the State of Nevada on June 4, 2008, under the name Ibex Resources Corp. The Company business at the time was mining and exploration of mineral properties. On August 31, 2009, the Company changed its name to Source Gold Corp. in order to reflect the focus of the Company. In April 2016, the Company changed its name to Golden Matrix Group, Inc., reflected the changing direction of the Company business to software technology. GMGI has a global presence with offices in Las Vegas Nevada and Sydney Australia. GMGI’s sophisticated social gaming software supports multiple languages including English and Chinese. The accompanying unaudited interim consolidated financial statements of Golden Matrix Group, Inc. (“GMGI” or the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (“SEC”), and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s annual report for the year ended July 31, 2019 on Form 10-K filed on October 23, 2019. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the consolidated financial statements which would substantially duplicate the disclosure contained in the audited consolidated financial statements for the most recent fiscal year ended July 31, 2019 have been omitted. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the balance sheet. Significant items subject to such estimates and assumptions include contingent liability, stock-based compensation, warrant valuation and collectability of accounts receivable. Actual results could differ from those estimates. Cash and Cash Equivalents For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents. The carrying value of these investments approximates fair value. Revenues According to Topic 606, Revenue Recognition Step 1: Identify the contract with a customer. Step 2: Identify the separate performance obligations in the contract. Step 3: Determine the transaction price. Step 4: Allocate the transaction price to the separate performance obligations in the contract. Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation. Earnings Per Common Share Basic net earnings per common share are computed by dividing net earnings available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted net earnings per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. The dilutive effect of outstanding stock options and warrants is reflected in diluted earnings per share by application of the treasury stock method. The dilutive effect of outstanding convertible securities is reflected in diluted earnings per share by application of the if-converted method. The following is a reconciliation of basic and diluted earnings per common share for 2019 and 2018: For the three ended October 31, 2019 2018 Basic earnings per common share Numerator: Net income available to common shareholders $ 545,888 $ 331,999 Denominator: Weighted average common shares outstanding 2,845,318,757 2,739,971,213 Basic earnings per common share $ 0.00 $ 0.00 Diluted earnings per common share Numerator: Net income available to common shareholders $ 545,888 $ 331,999 Denominator: Weighted average common shares outstanding 2,845,318,757 2,739,971,213 Preferred shares 1,000 1,000 Warrants/Options 1,346,962,264 - Convertible debt 8,176,667 35,562,500 Adjusted weighted average common shares outstanding 4,200,458,688 2,772,534,713 Diluted earnings per common share $ 0.00 $ 0.00 Derivative Instruments We review the terms of the common stock, warrants and convertible debt we issue to determine whether there are embedded derivative instruments, including embedded conversion options, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one embedded derivative instrument, including the conversion option, that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument. Bifurcated embedded derivatives are initially recorded at fair value and are then revalued at each reporting date with changes in the fair value reported as non-operating income or expense. When the equity or convertible debt instruments contain embedded derivative instruments that are to be bifurcated and accounted for as liabilities, the total proceeds received are first allocated to the fair value of all the bifurcated derivative instruments. The remaining proceeds, if any are then allocated to the host instruments themselves, usually resulting in those instruments being recorded as a discount from their face value. Derivatives are measured at their fair value on the balance sheet. Changes in fair value are recorded in the statement of operation. Income Taxes The Company uses the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statements carrying amounts of existing assets and liabilities and loss carry-forwards and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect of a change in tax rules on deferred tax assets and liabilities is recognized in operations in the year of change. A valuation allowance is recorded when it is “more likely-than-not” that a deferred tax asset will not be realized. Comprehensive Loss The Company is required to report comprehensive loss, which includes net loss as well as changes in equity from non-owner sources. Fair Value of Financial Instruments The Company measures its financial assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants at the measurement date. A three-tier fair value hierarchy prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: · Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; · Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable, such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and · Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one more significant inputs or significant value drivers are unobservable. Our financial instruments include cash, accounts payable and accrued liabilities, notes payable, convertible notes payable, advances from shareholder, and derivative liabilities. The carrying values of these financial instruments approximate their fair value due to their short-term nature. The derivative liabilities are stated at their fair value as a level 3 measurement. The Company used a Black-Scholes model to determine the fair values of these derivative liabilities. Stock-Based Compensation The Stock-based compensation expense is recorded as a result of stock options granted in return for services rendered. For the comparative periods, the share-based payment arrangements with employees were accounted for under ASC 718, while nonemployee share-based payments issued for goods and services are accounted for under ASC 505-50. ASC 505-50 differs significantly from ASC 718. On June 20, 2018, the FASB issued ASU 2018-07, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees would be aligned with the requirements for share-based payments granted to employees. The Company has adopted the new standard and has made some adjustment with regard to the share-based compensation costs during last fiscal year. Under the ASU 2018-07, the measurement of equity-classified nonemployee share-based payments is generally fixed on the grant date. And the options are no longer revalued on each reporting date. The expenses related to the share-based compensation are recognized on each reporting date. The amount is calculated as the difference between total expenses incurred and the total expenses already recognized. Subsequent Events The Company evaluated subsequent events through the date these financial statements were issued for disclosure purposes. Recent Issued Accounting Pronouncements In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) . Under the new guidance, lessees will be required to recognize all leases (with the exception of short-term leases) on the balance sheet as a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis and a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. The new standard is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period, with early application permitted. The new standard is to be applied using a modified retrospective approach. The Company does not have any lease agreements or have any contracts that contain lease elements. On June 20, 2018, the FASB issued ASU 2018-07, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees would be aligned with the requirements for share-based payments granted to employees. For public business entities (PBEs), the amendments in ASU 2018-07 are effective for fiscal years beginning after December 15, 2018, including interim periods therein. Early adoption is permitted if financial statements have not yet been issued (for PBEs), but no earlier than an entity’s adoption date of ASC 606. If early adoption is elected, all amendments in the ASU that apply must be adopted in the same period. In addition, if early adoption is elected in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. The Company has adopted the ASU 2018-07 and has adjusted the share-based compensation costs during last fiscal year. The management believes the new standard can best represent the company’s operating results. The Company does not believe that any other recently issued effective pronouncements, or pronouncements issued but not yet effective, if adopted, would have a material effect on the accompanying financial statements.

GOING CONCERN

GOING CONCERN	3 Months Ended
	Oct. 31, 2019
GOING CONCERN
NOTE 2 - GOING CONCERN	The accompanying unaudited consolidated financial statements of GMGI have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has suffered significant net losses from operations in prior periods and had an accumulated deficit of $ 25,891,847 as of October 31, 2019. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. During the quarter, the Company has generated a net profit of $545,888. The revenue growth during the quarter has produced solid profitability and excellent cash flow. The management plans to expand the customer base globally and to integrate additional operators, launch additional synergistic products and appoint more distributors to keep the growth of revenues. As such, the Company continues to adopt the going concern basis of accounting in preparing the consolidated financial statements.

NOTES PAYABLES

NOTES PAYABLES	3 Months Ended
	Oct. 31, 2019
NOTES PAYABLES
NOTE 3 - NOTES PAYABLES	Convertible Notes Payable Convertible notes payable at October 31, 2019 and July 31, 2019 consisted of the following: October 31, July 31, 2019 2019 Convertible Note #2 30,000 30,000 Convertible Note #59 - in default 10,000 10,000 Notes payable, principal $ 40,000 $ 40,000 Total notes payable, net of discount $ 30,000 $ 30,000 Total notes payable, net of discount - in default $ 10,000 $ 10,000 Convertible Note #2 On March 19, 2012, the Company received $30,000 cash from the issuance of a convertible promissory note in the amount of $30,000. The promissory note is unsecured, interest free and repayable upon demand. The note may be converted at the option of the holder into Common stock of the Company. The fixed conversion price is $0.01 per share. Accordingly the note may be converted into 3,000,000 common shares of the Company. The Company determined that this Promissory Note should be accounted for in accordance with FASB ASC 470-20 which addresses “Accounting for Convertible Securities with Beneficial Conversion Features”. The beneficial conversion feature is calculated at its intrinsic value (that is, the difference between the conversion price $0.01 and the fair value of the common stock into which the debt is convertible at the commitment date (per share being $0.08), multiplied by the number of shares into which the debt is convertible. The valuation of the beneficial conversion feature recorded cannot be greater than the face value of the note issued. On August 1, 2019, the Company, Pursuant to Chapter 104 - Uniform Commercial Code—Original Articles, NRS 104.3603 - Tender of payment. NV Rev Stat § 104.3603 (2013) and other applicable law, issued a Notice of Tender to Greenshoe by a registered letter. The Company is tendering payment in full of the currently outstanding balance of the Note, in the amount of $30,000. Such tender of payment by the Company to Greenshoe is in full discharge of the Company’s obligations under the Note #2. The registered letter has been returned to us as the registered address they provided is not available. The Company is now seeking legal opinions to address the liability. As of October 31, 2019, the principle balance of this note was $30,000. Convertible Note #59 On July 31, 2015 the Company entered into a Convertible Promissory Note with Direct Capital Group, Inc. in the sum of $240,000. The promissory note is unsecured, bears interest at 8% per annum, and matures on January 31, 2016. Any principal amount not paid by the maturity date bears interest at 22% per annum. On April 26, 2016, $50,000 was reassigned to Blackbridge Capital, LLC (“Blackbridge”). Blackbridge failed to meet terms of the Assignment and Assumption and were therefore in default of their obligations. The Company took legal advice regarding the breach of Blackbridge Capital LLC’s obligations. On the June 2, 2016, the Company’s legal counsel, wrote to Blackbridge Capital advising them of the breach and also that the Company had cancelled the remaining balance on the note. The Company recorded a gain on extinguishment of debt $47,151. On July 21, 2016, $25,000 was reassigned to Istvan Elek. At any time the note may be converted at the option of the holder into Common stock of the Company. The conversion price is 50% of the market price, where market price is defined as “the lowest closing price on any day with a fifteen day look back”. On September 22, 2016, the Company entered into a Cancellation and Release Agreement with Direct Capital Group, Inc. (“Direct”). In terms of Cancellation and Release Agreement Direct agreed to cancel the convertible promissory note with the Company totaling $183,157. In consideration for the cancellation of the convertible promissory notes and in terms of the Asset Purchase Agreement dated February 22, 2016, the Company has agreed to transfer ownership of mining claims held in the Company’s name. It was also agreed by both the Company and Direct that Direct shall release all future claims to subsequent conversions of the Notes and the Company will have no further obligation to Direct under those Convertible Notes and Direct shall be forever barred from seeking further conversions or claiming obligations of the Company under the Convertible Notes. The Company recorded a gain on extinguishment of debt of $165,000 related to the agreement. On August 1, 2019, the Company, Pursuant to Chapter 104 - Uniform Commercial Code—Original Articles, NRS 104.3603 - Tender of payment. NV Rev Stat § 104.3603 (2013) and other applicable law, issued a Notice of Tender to Istvan Elek by a registered letter. The Company is tendering payment in full of the currently outstanding balance of the Note, in the amount of $12,424. Such tender of payment by the Company to Istvan Elek is in full discharge of the Company’s obligations under the Note #59. The registered letter has been received by the counter party but the Company has not received any responses from Istvan Elek. The Company is now seeking legal opinions to address the liability. As of October 31, 2019, the principle balance of this note was $10,000, and the interest accrued was $2,626. Loans from Shareholders During the year ended July 31, 2016 and, the Company received a loan of $1,000 from its officer to open a new bank account. As of October 31, 2019, the balance of the loan was $1,000. The loan form the officers are due on demand, unsecured with no interest. Settlement Payable – Related Party On March 1, 2016 the Company entered into a convertible promissory note with Luxor Capital, LLC in the amount of $2,374,712. The promissory note is unsecured, bears interest at 6% per annum, and matures on March 1, 2017. Upon the holder’s option to convert becoming active the Company recorded a debt discount and derivative liability of $1,662,243 being the fair value of the conversion feature which was determined using the Black-Scholes valuation model based on the stock price of $0.2985, exercise price of $0.4264, time to maturity of 1 year and expected volatility of 1557%. The debt discount is accreted to the statement of operations using the effective interest rate method over the term of the note or to the date of conversion, and the derivative liability is revalued at each reporting date to fair value. Any change in fair value is credited or charged to the statement of operations in the period. On September 10, 2018, the Company entered into Settlement Agreement with Luxor Capital LLC (“Luxor”) whereby the parties agreed to release each other from any, and all liabilities relating to the Convertible Promissory Note. Pursuant to the Settlement Agreement, the Company agreed to pay out the remaining balance of the note totaling $649,414 by converting $209,414 into common stock at a conversion price $0.001, by making a payment of $150,000 and by entering into an interest free loan for the balance of $290,000, such loan to be repaid in two equal instalments of $145,000 on the September 10, 2019 and September 10, 2020. And no discount was recorded for the settlement amount. On September 10, 2018, 209,414,000 shares of common stock were issued for the conversion of $209,414. As of October 31, 2019, principal balance of this note was $0. The principle amount of $290,000 was transferred to settlement payable due to this Settlement Agreement. The $145,000 settlement payable due on September 10, 2019 was in default. Promissory Note Payable On February 28, 2018, the company entered into an Asset Purchase Agreement with Luxor Capital, LLC. Pursuant to the agreement the company purchased certain Intellectual Property and Knowhow (the “GM2 Asset”). In exchange for the GM2 asset, the company issued 625,000,000 shares of common stock valued at $187,500 based on closing market price on the date of the agreement as well as an earn-out payment which states that the Company, on or before April 30, 2019, will issue an earn-out note calculated at 50% of the revenues generated by the GM2 Asset system during the 12-month period of March 1, 2018 to February 28, 2019. During the period ended July 31, 2018, the Company recorded a contingent liability of $1,055,312. By the end of February 28, 2019, a $90,873 fair value loss on contingent liability was recognised due to the adjustment on the estimate of the potential future payments of the earn-out note. Related to the earn-out note, as of February 28, 2019, the Company recorded a contingent liability of $1,146,185 for the liability due to Luxor. On April 1, 2019, Luxor proposed 10% discount on the payable amount, the Company agreed to issue a Promissory Note of $1,031,567 regarding to the Asset Purchase agreement, $114,618 additional paid in capital was recorded for gain on extinguishment – related party. The note bears 6% interest rate. Pursuant to the Promissory Note, 20% of the total value shall be paid on signing the agreement, 40% of the total value shall be paid on October 1, 2019, and 40% of the total value including any accrued interest shall be paid on April 1, 2020. The late payment fee would be $500 per month. For the three months period ended October 31, 2019, the Company paid $398,313 to Luxor, LLC. As of October 31, 2019, the balance of the principle of Promissory Note was $633,254; interest accrued was $33,766, and a late fee payable was $3,500. The total amount was $670,520.

DERIVATIVE LIABILITIES

DERIVATIVE LIABILITIES	3 Months Ended
	Oct. 31, 2019
DERIVATIVE LIABILITIES
NOTE 4 - DERIVATIVE LIABILITIES	Due to the conversion features contained in the convertible notes issued, the actual number of shares of common stock that would be required if a conversion of the notes as further described in Note 6 was made through the issuance of the Company’s common stock cannot be predicted, and the Company could be required to issue an amount of shares that may cause it to exceed its authorized share amount. As a result, the conversion feature requires derivative accounting treatment and will be bifurcated from the notes and “marked to market” each reporting period through the income statement. The fair value of the conversion future of the notes was recognized as a derivative liability instrument and will be measured at fair value at each reporting period. For the three months ended October 31, 2019, there were no derivative liabilities recorded. For the comparable period, the Company recorded derivative liabilities of $33,000 for embedded conversion features of convertible notes payable. For the three months ended October 31, 2019 and 2018, the Company recorded an unrealised gain of $4,166 and a loss of $16,747 due to remeasurement of derivative securities. For the three month ended October 31, 2019, there were no gains or losses on settlement of derivative liabilities. For the comparable period, the Company recorded a gain on settlement of derivative liability of $5,310. At October 31, 2019 and 2018, the derivative liability associated with the note conversion features was $10,834 and $26,667, respectively. These derivative liabilities have been measured in accordance with fair value measurements, as defined by ASC 820. The valuation assumptions are classified within Level 1 and Level 2 inputs. The following table represents the Company’s derivative liability activity for the embedded conversion features discussed above: October 31, October 31, 2019 2018 Balance, beginning of period $ 15,000 $ 11,930 Initial recognition of derivative liability - 3,300 Conversion of derivative liability to Common Stock - - Mark-to-Market adjustment to fair value (4,166 ) 16,747 (Gain) on settlement agreement - (5,310 ) Balance, end of period $ 10,834 $ 26,667

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Oct. 31, 2019
COMMITMENTS AND CONTINGENCIES
NOTE 5 - COMMITMENTS AND CONTINGENCIES	Legal Proceedings From time to time, we may be party to litigation or other legal proceedings that we consider to be a part of the ordinary course of our business. We are not involved currently in legal proceedings other than those detailed below that could reasonably be expected to have a material adverse effect on our business, prospects, financial condition or results of operations. We may become involved in material legal proceedings in the future.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended
	Oct. 31, 2019
RELATED PARTY TRANSACTIONS
NOTE 6 - RELATED PARTY TRANSACTIONS	All related party transactions have been recorded at the exchange value which was the amount of consideration established and agreed to by the related parties. Luxor Capital, LLC On February 22, 2016, the Company entered into an Asset Purchase Agreement with Luxor Capital, LLC, which is wholly owned by Anthony Goodman, CEO of the Company. The Company purchased a Certain Gaming IP, along with the “know how” of that Gaming IP from Luxor. Pursuant to the Asset Purchase Agreement, 11,112 shares of common stock have been issued to Luxor Capital, LLC and its designed party. On March 1 2016, the Company issued a convertible promissory note to Luxor. The Company promised to pay to Luxor the principal amount of $2,874,712 together with any accrued interest at a rate of 6%. On September 10, 2018, the Company entered into Settlement Agreement and Mutual General Release Agreement (the “Settlement Agreement”) with Luxor to release all liabilities relating to the Convertible Note issued on March 1, 2016 (the “Note”), the Company agreed to pay out the remaining balance totalling $649,414 by converting $209,414 into common stock at a conversion price $0.001, and a payment of $150,000, and by entering into an interest free loan for the remaining balance of $290,000. As of October 31, 2019, the interest free loan consisted of the settlement payable of $290,000. Although Luxor did not charge interest on this loan, the imputed interest was still recorded. On February 28, 2018, the Company entered into an Asset Purchase Agreement with Luxor to acquire certain Intellectual Property and Know-how ( the “GM2Asset), the aggregate purchase price was 625,000,000 shares of common stock valued at $187,500 on the date of issuance and an Earnout Note Payable calculated at 50% of the revenues generated by GM2 during the 12-month period from March 1, 2018 to February 28, 2019. On April 1, 2019, $1,146,185 contingent liability related to the Earnout Note was recognized. The GM2 Asset is expected to lead to new clients and incremental revenues by allowing the Company to offer unique IP to Social Gaming Clientele. On April 1, 2019, the Company issued a Promissory Note in terms of the Asset Purchase Agreement with Luxor entered on February 28, 2018. Luxor has proposed a 10% discount to the amount of the Promissory Note. The note bears 6% interest rate. As of October 31, 2019, the balance of the principle of Promissory Note was $633,254; interest accrued was $ 33,766, and a late fee payable was $3,500. The total amount was $670,520. Brian Goodman On February 22, 2016, the Company entered into a Consulting Service Agreement with its Chief Executive Officer, Anthony Goodman. Pursuant to the Agreement, the consulting fee could be settled in shares. On December 12, 2017, the Company issued 77,780,659 shares of common stock to settle account payable of $30,000 to Mr. Goodman. On June 18, 2018, the Company issued 25,000,000 shares of common stock to settle account payable of $30,000,000 to Mr. Goodman. As of October 31, 2019, the Company has a $142,042 payable to Mr. Goodman. On January 3, 2018, the Company granted a stock option plan: the 2018 Equity Incentive Plan. In terms of this plan, on January 3, 2018 and September 19, 2019, the Company issued share options to Brian Goodman. More details of the options are covered in Note 7 Equity. Weiting Feng On February 22, 2016, the Company entered into a Consulting Service Agreement with its Chief Financial Officer, Weiting Feng. Pursuant to the Agreement, the consulting fee could be settled in shares. On December 12, 2017, the Company issued 77,780,659 shares of common stock to settle account payable of $30,000 to Ms, Feng. On June 18, 2018, the Company issued 25,000,000 shares of common stock to settle account payable of $30,000,000 to Ms. Feng. As of October 31, 2019, the Company has a $166,017 payable to Ms. Feng. On January 3, 2018, the Company granted a stock option plan: the 2018 Equity Incentive Plan. In terms of this plan, on January 3, 2018 and September 16, 2019, the Company issued share options to Weiting Feng. More details of the options are covered in Note 7 Equity. Articulate Pty Ltd On April 1, 2016, the Company entered into a Services Agreement with Articulate Pty Ltd, which is wholly owned by Anthony Goodman, CEO of the Company, for consulting services. Pursuant to the agreement Articulated would receive $4,500 per month for services rendered and reimbursement of office expenses from the Company. On January 1, 2018, the Company amended the Back Office Agreement, in which Articulate discontinued to provided services, however the term of the Back Office Agreement will continue for a further 12 months for with regard to further co-operation. On December 1, 2018, the Company entered into an Amendment to Back Office Agreement with Articulate Pty Ltd. The Company shall increase the contribution from $2,300 per month to $5,500 per month. On August 1, 2019, the Company entered into a Second Amendment to Back Office Agreement with Articulate Pty Ltd. The Parties have conducted discussions with regard to GMGI’s contribution. Based on the increased utilisation of office space, increased use of utilities, and accounting resources, the Parties have agreed to increase the contribution from $5,500 per month to $11,000 per month. For the three months ended October 31, 2019 and 2018, general and administrative expense related to the back office service was $33,000 and $ $39,300, respectively. As of October 31, 2019, the Company has a $ 281,591 payable to Articulate Pty Ltd. On March 1, 2018, the Company entered into a License Agreement with Articulate, in which Articulate received a license from the Company to use GM2 Asset technology, and would pay the Company a usage fee calculated as a certain percentage of the monthly content and software usage within the GM2 Assent system. From July 1, 2018, the Company provided system for usage in additional currency, a lower usage fee scale was agreed in an Addendum for the additional market. During the three months ended October 31, 2019, revenue form Articulate was $519,569. As of October 31, 2019, the Company had a $576,627 accounts receivable from Articulate. Globaltech Software Services LLC On June 1, 2016, the Company entered a distribution usage rights agreement with Globaltech Software Services LLC. (“Globaltech”), a company in which Anthony Goodman the Chief Executive Officer has an interest. The Company agreed to provide certain proprietary technology in the form of a Credit Management system, Social Gaming system and other Marketing and Gaming Technology. This agreement not only brings operating revenue to the Company, but also solidifies the Company’s expertise in the social gaming market. On December 1, 2018, the Company entered into an Cancellation of Distribution Usage Rights Agreement with Globaltech. The parties have agreed to suspend minimum monthly charge from December 1, 2018 and work together to enter into a Co-operation agreement in coming months. During the three months ended October 31, 2019 and 2018, revenue from Globaltech was $0 and $30,000, respectively. As of October 31, 2019, the Company had a $10,839 accounts receivable from Globaltech.

EQUITY

EQUITY	3 Months Ended
	Oct. 31, 2019
EQUITY
NOTE 7 - EQUITY	Preferred Stock The Company authorized the creation of 20,000,000 shares of it $0.00001 par value preferred stock. On August 10, 2015, the Company’s Board of Directors authorized the creation of 1,000 shares of Series B Voting Preferred Stock. The holder of the shares of the Series B Voting Preferred Stock has the right to vote those shares of the Series B Voting Preferred Stock regarding any matter or action that is required to be submitted to the shareholders of the Company for approval. The vote of each share of the Series B Voting Preferred Stock is equal to and counted as 4 times the votes of all of the shares of the Company’s (i) common stock, and (ii) other voting preferred stock issued and outstanding on the date of each and every vote or consent of the shareholders of the Company regarding each and every matter submitted to the shareholders of the Company for approval. On August 10, 2015, the Company filed a Certificate of Designation with the Nevada Secretary of State creating the 1,000 shares of Series B Voting Preferred Stock On August 14, 2015, the Company issued 1,000 shares of Series B Voting Preferred Stock to Santa Rosa Resources, representing 100% of the total issued and outstanding shares of the Company’s Series B Voting Preferred Stock. On April 3, 2016, the Company cancelled 1,000 shares of Series B Voting Preferred Stock to Santa Rosa Resources and a new certificate issued in the name of Luxor Capital LLC in the amount of 1,000 Series B shares. As of October 31, 2019, 19,999,000 Series A preferred shares and 1,000 Series B preferred shares of par value $0.00001 were authorized, of which 0 Series A shares were issued and outstanding, 1,000 Series B shares were issued and outstanding. Common Stock The Company authorized the creation of 6,000,000,000 shares of its $0.00001 par value common stock. During the three months ended October 31, 2019, there was no issuance of shares. As of October 31, 2019, 6,000,000,000 common shares of par value $0.00001 were authorized, of which 2,845,318,757 shares were issued and outstanding. Stock Option Plan On January 3, 2018, the Company granted a stock option plan: the 2018 Equity Incentive Plan. The fair value of stock option was measured using the Black-Scholes option pricing model. The Black-Scholes valuation model takes into consideration the share price of the Company, the exercise price of the option, the amount of time before the option expires, and the volatility of share price. The compensation expense will be charged to operations through the vesting period. The amount of cost will be calculated based on the new accounting standard ASU 2018-07. (a) External Consultants: On January 3, 2018, the Company granted stock options to 9 external consultants, each of them was granted to purchase 30,000,000 shares of common stock of the Company at exercise price of $0.0004 with vesting period of three years, vesting 33% each anniversary for three years. The expiration date will be June 30, 2021. The fair value of each consultant’s option was $11,877 on the grant date based on the share price of $0.0004 on the granting date, exercise price of $0.0004, time to maturity of 3.5 years, and stock price volatility of 273%. During the financial year 2018, two of the consultants have resigned, and their options were forfeited. During the financial year 2019, another two of the consultants have resigned, but one third of their options were vested. As of October 31, 2019, 60,000,000 options above were vested. Except for the forfeited options, the fair value of the stock options above was $71,260 in total on the grant date. On March 15, 2018, the Company granted stock options to an external consultant, James Young. The consultant was granted to purchase 210,000,000 shares of common stock of the Company at exercise price of $0.0004 with vesting period of three years, vesting 33% each anniversary for three years. The expiration date will be June 30, 2021. The fair value of the option was $41,209 on the grant date based on the share price of $0.0002 on the granting date, exercise price $0.0004, time to maturity of 3.5 years, and stock volatility of 263%. As of October 31, 2019, 70,000,000 options were vested. On May 8, 2018, the Company granted stock options to an external consultant, Siu Kei Ho. The consultant was granted to purchase 75,000,000 shares of common stock of the Company at exercise price of $0.0004 with vesting period of three years. The expiration date will be June 30, 2021. Since the consultant did not perform services as anticipated and specified in the consulting agreement, on May 8, 2019, the Company terminated the consulting agreement and all compensation specified in the agreement with Siu Kei Ho. On August 3, 2018, the Company granted stock options to an external consultant, Hongfei Zhang. The consultant was granted to purchase 30,000,000 shares of common stock of the Company at exercise price of $0.0008 with vesting period of three years, vesting 33% each anniversary for three years. The expiration date will be June 30, 2021. The fair value of the stock options was $22,056 on the grant date based on the share price of $0.0008 on the grant date, exercise price of $0.0008, time to maturity of 3.5 years, and stock volatility of 345%. As of October 31, 2019, 10,000,000 options were vested. On November 28, 2018, the Company granted stock options to an external consultant, Su He. The consultant was granted to purchase 30,000,000 shares of common stock of the Company at exercise price of $0.0011 with vesting period of three years, vesting 33% each anniversary for three years. The expiration date will be May 29, 2022. The fair value of the stock options was $29,869 on the grant date based on the share price of $0.0011 on the grant date, exercise price of $0.0011, time to maturity of 3.5 years, and stock volatility of 329%. On April 9, 2019 the Company entered a Consultant Agreement and granted stock options to an external consultant, Marc Mcalister. The consultant was granted to purchase 15,000,000 shares of common stock of the Company at exercise price of $0.0022 with vesting period of half year, vesting 100% on October 9, 2019. The expiration date will be April 9, 2020. The fair value of the stock options was $16,820 on the grant date based on the share price of $0.0022 on the grant date, exercise price of $0.0022, time to maturity of 1 year, and stock volatility of 136%. On April 9, 2019 the Company entered a Consultant Agreement and granted stock options to an external consultant, Michael Davies. The consultant was granted to purchase 8,000,000 shares of common stock of the Company at exercise price of $0.0022 with vesting period of half year, vesting 100% on October 9, 2019. The expiration date will be April 9, 2020. The fair value of the stock options was $8,971 on the grant date based on the share price of $0.0022 on the grant date, exercise price of $0.0022, time to maturity of 1 year, and stock volatility of 136%. On June 11, 2019, the Company granted stock options to an external consultant, Zhe Yan. The consultant was granted to purchase 30,000,000 shares of common stock of the Company at exercise price of $0.0032 with vesting period of three years, vesting 33% each anniversary for three years. The expiration date will be December 11, 2022. The fair value of the stock options was $75,312 on the grant date based on the share price of $0.0032 on the grant date, exercise price of $0.0032, time to maturity of 3.5 years, and stock volatility of 244%. On June 11, 2019, the Company granted stock options to an external consultant, Yukun Qiu. The consultant was granted to purchase 30,000,000 shares of common stock of the Company at exercise price of $0.0032 with vesting period of three years, vesting 33% each anniversary for three years. The expiration date will be December 11, 2022. The fair value of the stock options was $75,312 on the grant date based on the share price of $0.0032 on the grant date, exercise price of $0.0032, time to maturity of 3.5 years, and stock volatility of 244%. The cost of sales related to the options were $32,193 in total for the three months ended October 31, 2019. (b) Directors: The Company granted stock options to its Chief Financial Officer to purchase 210,000,000 shares of common stock of the Company at exercise price of $0.0004 with vesting period of one and a half years, vesting 33% each half year. The fair value of the stock option was $69,615 on August 1, 2018 based on the share price of $0.0004, exercise price of $0.0004, time to maturity of 1 year, and stock volatility of 273%. As of October 31, 2019, the options were fully vested. On September 16, 2019, the Company passed a board resolution to extend the expiration date from December 30, 2019 to June 30, 2020. The Company granted stock options to its Chief Executive Officer to purchase 810,000,000 shares of common stock of the Company at exercise price of $0.00044 with vesting period of one and a half years, vesting 33% each half year for one and a half years. The fair value of the stock option was $265,821 on August 1, 2018 based on the share price of $0.0004, exercise price of $0.00044, time to maturity of 1 year, and stock volatility of 273%. As of October 31, 2019, the options were fully vested. On September 16, 2019, the Company passed a board resolution to extend the expiration date from December 30, 2019 to June 30, 2020. On September 19, 2019, the Company granted stock options to its Chief Financial Officer to purchase 105,000,000 shares of common stock of the Company at exercise price of $0.0055 with vesting period of one and a half years, vesting 33% each half year. The fair value of the stock option was $332,446 on September 19, 2019 based on the share price of $0.0055, exercise price of $0.0055, time to maturity of 2 years, and stock volatility of 111%. On September 19, 2019, the Company granted stock options to its Chief Executive Officer to purchase 405,000,000 shares of common stock of the Company at exercise price of $0.00605 with vesting period of one and a half years, vesting 33% each half year. The fair value of the stock option was $1,236,381 on September 19, 2019 based on the share price of $0.0055, exercise price of $0.00605, time to maturity of 2 years, and stock volatility of 111%. As of October 31, 2019, 1,020,000,000 stock options granted to directors were vested; $120,679 amortization expense was recorded related to the director’s options for the three months ended October 31, 2019.

CONCENTRATION

CONCENTRATION	3 Months Ended
	Oct. 31, 2019
CONCENTRATION
NOTE 8 - CONCENTRATION	At the present time, we are dependent on a small number of direct customers for most of our business, revenue and results of operations. The Company’s major revenues for the three months ended July 31, 2019 were from two customers, Articulate Pty Ltd and Red Label Technology Pty Ltd. For the three months ended October 31, 2019, the aggregate amount of revenues from the two customers were $881,845. Articulate Pty Ltd accounted for 59% and Red Label Technology Pty Ltd accounted for 41%. As of October 31, 2019, the net amount of accounts receivable from the two customers were $1,070,300. Articulate Pty Ltd accounted for 44% and Red Label Technology Pty Ltd accounted for 55%. For the three months period ended October 31, 2019, the total cash received from Articulate Pty Ltd was $931,500 and accounted for 86% of total cash received from customers. The Company maintains strong relationship with these two customers and expect to engage with additional customers in the coming period.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Oct. 31, 2019
SUBSEQUENT EVENTS
NOTE 9 - SUBSEQUENT EVENTS	None.

BASIS OF PRESENTATION AND ACC_2

BASIS OF PRESENTATION AND ACCOUNTING POLICIES (Policies)	3 Months Ended
	Oct. 31, 2019
BASIS OF PRESENTATION AND ACCOUNTING POLICIES (Policies)
Use of Estimates	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the balance sheet. Significant items subject to such estimates and assumptions include contingent liability, stock-based compensation, warrant valuation and collectability of accounts receivable. Actual results could differ from those estimates.
Cash and Cash Equivalents	For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents. The carrying value of these investments approximates fair value.
Revenues	According to Topic 606, Revenue Recognition Step 1: Identify the contract with a customer. Step 2: Identify the separate performance obligations in the contract. Step 3: Determine the transaction price. Step 4: Allocate the transaction price to the separate performance obligations in the contract. Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation.
Earnings Per Common Share	Basic net earnings per common share are computed by dividing net earnings available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted net earnings per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. The dilutive effect of outstanding stock options and warrants is reflected in diluted earnings per share by application of the treasury stock method. The dilutive effect of outstanding convertible securities is reflected in diluted earnings per share by application of the if-converted method. The following is a reconciliation of basic and diluted earnings per common share for 2019 and 2018: For the three ended October 31, 2019 2018 Basic earnings per common share Numerator: Net income available to common shareholders $ 545,888 $ 331,999 Denominator: Weighted average common shares outstanding 2,845,318,757 2,739,971,213 Basic earnings per common share $ 0.00 $ 0.00 Diluted earnings per common share Numerator: Net income available to common shareholders $ 545,888 $ 331,999 Denominator: Weighted average common shares outstanding 2,845,318,757 2,739,971,213 Preferred shares 1,000 1,000 Warrants/Options 1,346,962,264 - Convertible debt 8,176,667 35,562,500 Adjusted weighted average common shares outstanding 4,200,458,688 2,772,534,713 Diluted earnings per common share $ 0.00 $ 0.00
Derivative Instruments	We review the terms of the common stock, warrants and convertible debt we issue to determine whether there are embedded derivative instruments, including embedded conversion options, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one embedded derivative instrument, including the conversion option, that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument. Bifurcated embedded derivatives are initially recorded at fair value and are then revalued at each reporting date with changes in the fair value reported as non-operating income or expense. When the equity or convertible debt instruments contain embedded derivative instruments that are to be bifurcated and accounted for as liabilities, the total proceeds received are first allocated to the fair value of all the bifurcated derivative instruments. The remaining proceeds, if any are then allocated to the host instruments themselves, usually resulting in those instruments being recorded as a discount from their face value. Derivatives are measured at their fair value on the balance sheet. Changes in fair value are recorded in the statement of operation.
Income Taxes	The Company uses the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statements carrying amounts of existing assets and liabilities and loss carry-forwards and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect of a change in tax rules on deferred tax assets and liabilities is recognized in operations in the year of change. A valuation allowance is recorded when it is “more likely-than-not” that a deferred tax asset will not be realized.
Comprehensive Loss	The Company is required to report comprehensive loss, which includes net loss as well as changes in equity from non-owner sources.
Fair Value of Financial Instruments	The Company measures its financial assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants at the measurement date. A three-tier fair value hierarchy prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: · Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; · Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable, such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and · Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one more significant inputs or significant value drivers are unobservable. Our financial instruments include cash, accounts payable and accrued liabilities, notes payable, convertible notes payable, advances from shareholder, and derivative liabilities. The carrying values of these financial instruments approximate their fair value due to their short-term nature. The derivative liabilities are stated at their fair value as a level 3 measurement. The Company used a Black-Scholes model to determine the fair values of these derivative liabilities.
Stock-Based Compensation	The Stock-based compensation expense is recorded as a result of stock options granted in return for services rendered. For the comparative periods, the share-based payment arrangements with employees were accounted for under ASC 718, while nonemployee share-based payments issued for goods and services are accounted for under ASC 505-50. ASC 505-50 differs significantly from ASC 718. On June 20, 2018, the FASB issued ASU 2018-07, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees would be aligned with the requirements for share-based payments granted to employees. The Company has adopted the new standard and has made some adjustment with regard to the share-based compensation costs during last fiscal year. Under the ASU 2018-07, the measurement of equity-classified nonemployee share-based payments is generally fixed on the grant date. And the options are no longer revalued on each reporting date. The expenses related to the share-based compensation are recognized on each reporting date. The amount is calculated as the difference between total expenses incurred and the total expenses already recognized.
Subsequent Events	The Company evaluated subsequent events through the date these financial statements were issued for disclosure purposes.
Recent Issued Accounting Pronouncements	In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) . Under the new guidance, lessees will be required to recognize all leases (with the exception of short-term leases) on the balance sheet as a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis and a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. The new standard is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period, with early application permitted. The new standard is to be applied using a modified retrospective approach. The Company does not have any lease agreements or have any contracts that contain lease elements. On June 20, 2018, the FASB issued ASU 2018-07, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees would be aligned with the requirements for share-based payments granted to employees. For public business entities (PBEs), the amendments in ASU 2018-07 are effective for fiscal years beginning after December 15, 2018, including interim periods therein. Early adoption is permitted if financial statements have not yet been issued (for PBEs), but no earlier than an entity’s adoption date of ASC 606. If early adoption is elected, all amendments in the ASU that apply must be adopted in the same period. In addition, if early adoption is elected in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. The Company has adopted the ASU 2018-07 and has adjusted the share-based compensation costs during last fiscal year. The management believes the new standard can best represent the company’s operating results. The Company does not believe that any other recently issued effective pronouncements, or pronouncements issued but not yet effective, if adopted, would have a material effect on the accompanying financial statements.

BASIS OF PRESENTATION AND ACC_3

BASIS OF PRESENTATION AND ACCOUNTING POLICIES (Tables)	3 Months Ended
	Oct. 31, 2019
BASIS OF PRESENTATION AND ACCOUNTING POLICIES (Policies)
Basic and diluted earnings (loss) per common share	For the three ended October 31, 2019 2018 Basic earnings per common share Numerator: Net income available to common shareholders $ 545,888 $ 331,999 Denominator: Weighted average common shares outstanding 2,845,318,757 2,739,971,213 Basic earnings per common share $ 0.00 $ 0.00 Diluted earnings per common share Numerator: Net income available to common shareholders $ 545,888 $ 331,999 Denominator: Weighted average common shares outstanding 2,845,318,757 2,739,971,213 Preferred shares 1,000 1,000 Warrants/Options 1,346,962,264 - Convertible debt 8,176,667 35,562,500 Adjusted weighted average common shares outstanding 4,200,458,688 2,772,534,713 Diluted earnings per common share $ 0.00 $ 0.00

NOTES PAYABLES (Tables)

NOTES PAYABLES (Tables)	3 Months Ended
	Oct. 31, 2019
NOTES PAYABLES
Summary of Convertible Notes Payable	October 31, July 31, 2019 2019 Convertible Note #2 30,000 30,000 Convertible Note #59 - in default 10,000 10,000 Notes payable, principal $ 40,000 $ 40,000 Total notes payable, net of discount $ 30,000 $ 30,000 Total notes payable, net of discount - in default $ 10,000 $ 10,000

DERIVATIVE LIABILITIES (Tables)

DERIVATIVE LIABILITIES (Tables)	3 Months Ended
	Oct. 31, 2019
DERIVATIVE LIABILITIES (Tables)
Schedule of derivative liability	October 31, October 31, 2019 2018 Balance, beginning of period $ 15,000 $ 11,930 Initial recognition of derivative liability - 3,300 Conversion of derivative liability to Common Stock - - Mark-to-Market adjustment to fair value (4,166 ) 16,747 (Gain) on settlement agreement - (5,310 ) Balance, end of period $ 10,834 $ 26,667

BASIS OF PRESENTATION AND ACC_4

BASIS OF PRESENTATION AND ACCOUNTING POLICIES (Details) - USD ($)	3 Months Ended
	Oct. 31, 2019	Oct. 31, 2018
Numerator:
Net income (loss)	$ 545,888	$ 331,999
Denominator:
Weighted average common shares outstanding	2,845,318,757	2,739,971,213
Basic earnings (loss) per common share	$ 0	$ 0
Numerator:
Net income available to common shareholders	$ 545,888	$ 331,999
Denominator:
Weighted average common shares outstanding	2,845,318,757	2,739,971,213
Preferred shares	1,000	1,000
Warrants/Options	1,346,962,264
Convertible debt	8,176,667	35,562,500
Adjusted weighted average common shares outstanding	4,200,458,688	2,772,534,713
Diluted earnings (loss) per common share	$ 0	$ 0

BASIS OF PRESENTATION AND ACC_5

BASIS OF PRESENTATION AND ACCOUNTING POLICIES (Details Narrative)	3 Months Ended
	Oct. 31, 2019
BASIS OF PRESENTATION AND ACCOUNTING POLICIES (Details Narrative)
State of incorporation	Nevada
Date of incorporation	Jun. 4, 2008

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative) - USD ($)	3 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Jul. 31, 2019
GOING CONCERN (Details Narrative)
Net income (loss)	$ 545,888	$ 331,999
Accumulated deficit	$ (25,891,847)		$ (26,437,735)

NOTES PAYABLES (Details)

NOTES PAYABLES (Details) - USD ($)	Oct. 31, 2019	Aug. 02, 2019	Jul. 31, 2019	Jul. 31, 2018
Notes payable, principal	$ 40,000		$ 40,000
Total notes payable, net of discount	30,000		30,000
Total notes payable, net of discount - in default	10,000		10,000
Convertible Note 2 [Member]
Notes payable, principal	30,000	$ 30,000	30,000	$ 30,000
Convertible Note 59 [Member]
Notes payable, principal	$ 10,000		$ 10,000	$ 10,000

NOTES PAYABLES (Details Narrati

NOTES PAYABLES (Details Narrative) - USD ($)

Sep. 10, 2018

Dec. 12, 2017

Mar. 01, 2016

Jun. 18, 2018

Feb. 28, 2018

Sep. 22, 2016

Jul. 21, 2016

Apr. 26, 2016

Jul. 31, 2015

Mar. 19, 2012

Aug. 23, 2019

Oct. 31, 2019

Oct. 31, 2018

Apr. 30, 2018

Apr. 30, 2019

Apr. 30, 2018

Aug. 02, 2019

Jul. 31, 2019

Feb. 28, 2019

Jul. 31, 2018

Net fair value loss on contingent liability

$ 90,873

Contingent liability

$ 1,055,312

Convertible note, principal amount

$ 0

Convertible promissory note, balance

40,000

$ 40,000

Accrued interest

12,005

$ 4,494

Advances from shareholders

1,000

1,000

Derivative liability

10,834

26,667

15,000

11,930

Gain on extinguishment of debt

(106)

Settlement payable

448,012

Luxor Capital Llc [Member]

Convertible note, principal amount

$ 649,414

Notes payable

398,313

Convertible promissory note, balance

633,254

Accrued interest

33,766

Late payment fee

3,500

Convertible promissory note, total amount

670,520

Loan payable

$ 290,000

Convertible debt

633,254

Conversion price

$ 0.001

Debt conversion converted instrument shares issued

209,414,000

Amount payable under agreement

$ 150,000

Luxor Capital Llc [Member] | Settlement Agreement [Member]

Convertible note, principal amount

649,414

Loan payable

$ 290,000

Maturity date

Sep. 10, 2019

Conversion price

$ 0.001

Settlement payable

$ 145,000

Debt conversion converted amount

$ 209,414

Debt conversion converted instrument shares issued

209,414,000

Amount payable under agreement

$ 150,000

Amount transferred to settlement payable

290,000

Luxor Capital Llc [Member] | Settlement Agreement [Member] | First installment [Member]

Loan payable

$ 145,000

Maturity date

Sep. 10, 2019

Luxor Capital Llc [Member] | Settlement Agreement [Member] | Second installment [Member]

Loan payable

$ 145,000

Maturity date

Sep. 10, 2020

Luxor Capital Llc [Member] | Asset Purchase Agreement [Member]

Contingent liability

$ 1,146,185

Assets term period

Asset during the 12-month period of March 1, 2018 to February 28, 2019

Revenues percentage

50.00%

Common stock issued for acquisition, value

$ 187,500

Convertible Note 2 [Member]

Convertible promissory note, balance

30,000

$ 30,000

30,000

30,000

Convertible debt

$ 30,000

Proceeds from issuance of promissory notes

$ 30,000

Conversion price

$ 0.01

Common stock shares issuable upon conversion of convertible notes

3,000,000

Beneficial conversion feature

The beneficial conversion feature is calculated at its intrinsic value (that is, the difference between the conversion price $0.01 and the fair value of the common stock into which the debt is convertible at the commitment date (per share being $0.08), multiplied by the number of shares into which the debt is convertible.

Convertible Note 59 [Member]

Convertible promissory note, balance

10,000

$ 10,000

10,000

Accrued interest

2,626

Interest rate

8.00%

Convertible debt

$ 50,000

$ 240,000

Maturity date

Jan. 31, 2016

Penalty rate

22.00%

Gain on extinguishment of debt

$ 47,151

Convertible Note 59 [Member] | Cancellation and Release Agreement [Member]

Convertible debt

$ 183,157

Gain on extinguishment of debt

$ 165,000

Convertible Note 59 [Member] | Istvan Elek [Member]

Notes payable

12,424

Convertible debt

$ 25,000

Conversion price as a percentage of market price

50.00%

April 1, 2019 [Member] | Luxor Capital Llc [Member] | Asset Purchase Agreement [Member]

Late payment fee

500

Additional paid in capital related to gain on extinguishment of related party debt

$ 114,618

Interest rate

6.00%

Promissory note to be issued under agreement

$ 1,031,567

Agreement description

20% of the total value shall be paid on signing the agreement, 40% of the total value shall be paid on October 1, 2019, and 40% of the total value including any accrued interest shall be paid on April 1, 2020.

Officer [Member] | July 31, 2016 [Member]

Advances from shareholders

$ 1,000

Loan payable

1,000

Settlement Payable [Member] | Convertible Note 59 [Member]

Convertible promissory note, balance

$ 495,712

Interest rate

6.00%

Convertible debt

$ 2,374,712

Maturity date

Mar. 1, 2017

Debt discount

$ 1,662,243

Derivative liability

$ 1,662,243

Stock price

$ 0.2985

Exercise price

$ 0.4264

Maturity period

1 year

Expected volatility

1557.00%

DERIVATIVE LIABILITIES (Details

DERIVATIVE LIABILITIES (Details) - USD ($)	3 Months Ended
	Oct. 31, 2019	Oct. 31, 2018
DERIVATIVE LIABILITIES (Details)
Balance, beginning of period	$ 15,000	$ 11,930
Initial recognition of derivative liability		3,300
Conversion of derivative liability to Common Stock
Mark-to-Market adjustment to fair value	(4,166)	16,747
(Gain) on settlement agreement		(5,310)
Balance, end of period	$ 10,834	$ 26,667

DERIVATIVE LIABILITIES (Detai_2

DERIVATIVE LIABILITIES (Details Narrative) - USD ($)	3 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Jul. 31, 2019
Gain (loss) on derivative liability	$ 4,166	$ 16,747
Gain on settlement of derivative liabilities	5,310
Derivative liability related to conversion feature	10,834	$ 26,667
Derivative liabilities - conversion feature	10,834		$ 15,000
Convertible Note Payable [Member]
Derivative liabilities - conversion feature	$ 33,000

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	Sep. 10, 2018	Dec. 12, 2017	Apr. 01, 2016	Jun. 18, 2018	Feb. 28, 2018	Aug. 23, 2019	Oct. 31, 2019	Oct. 31, 2018	Jul. 31, 2019	Apr. 01, 2019	Feb. 28, 2019	Jul. 31, 2018	Jul. 31, 2017	Mar. 01, 2016	Feb. 22, 2016
Settlement Payable							$ 290,000		$ 145,000
Common stock, shares issued							2,845,318,757		2,845,318,757			2,622,904,757
Convertible note, principal amount							$ 0
General and administrative expense - related party							33,000	$ 39,300
Accounts receivable							482,834		$ 264,558
Luxor Capital LLC [Member] | Convertible promissory note [Member]
Convertible note, principal amount														$ 2,874,712
Accrued interest														6.00%
Luxor Capital LLC [Member] | Promissory Note [Member] | Asset Purchase Agreement [Member]
Proposed discount										10.00%
Interest rate										6.00%
Mr. Goodman [Member]
Common stock, shares issued		77,780,659		25,000,000
Accounts payable - related parties							142,042
Shares issued for settlement of accounts payable - related party		$ 30,000		$ 30,000,000
Ms.Weiting Feng [Member]
Common stock, shares issued		77,780,659		25,000,000
Accounts payable - related parties							166,017
Shares issued for settlement of accounts payable - related party		$ 30,000		$ 30,000,000
Luxor Capital Llc [Member]
Convertible promissory note, total amount							670,520
Late payment fee							3,500
Convertible debt							633,254
Accrued interest							$ 33,766
Common stock, shares issued															11,112
Convertible note, principal amount	$ 649,414
Interest free loan payable under agreement	290,000
Amount payable under agreement	$ 150,000
Conversion price	$ 0.001
Debt conversion converted instrument shares issued	209,414,000
Debt conversion converted amount	$ 209,414
Luxor Capital Llc [Member] | Asset Purchase Agreement [Member]
Common stock issued for acquisition, shares					625,000,000
Common stock issued for acquisition, value					$ 187,500
Contingent liability-related party											$ 1,146,185
Revenues percentage					50.00%
Assets term period					Asset during the 12-month period of March 1, 2018 to February 28, 2019
Luxor Capital Llc [Member] | Settlement Agreement [Member]
Convertible note, principal amount	649,414
Interest free loan payable under agreement	290,000
Amount payable under agreement	$ 150,000
Conversion price	$ 0.001
Debt conversion converted instrument shares issued	209,414,000
Luxor Capital Llc [Member] | Convertible promissory note [Member] | Settlement Agreement [Member]
Interest free loan payable under agreement							290,000
Articulate Pty Ltd [Member]
Accounts payable - related parties							$ 281,591
Increase the contribution description						the Parties have agreed to increase the contribution from $5,500 per month to $11,000 per month.	The Company shall increase the contribution from $2,300 per month to $5,500 per month.
Consulting fees per month			$ 4,500
General and administrative expense - related party							$ 33,000	39,300
Accounts receivable							576,627
Sales- revenue related party							519,569
Globaltech [Member]
Accounts receivable							10,839
Sales- revenue related party							$ 0	$ 30,000

EQUITY (Details Narrative)

EQUITY (Details Narrative)

Jun. 11, 2019USD ($)$ / sharesshares

Apr. 09, 2019USD ($)$ / sharesshares

Aug. 03, 2018USD ($)$ / sharesshares

May 08, 2018USD ($)$ / sharesshares

Mar. 15, 2018USD ($)$ / sharesshares

Jan. 03, 2018USD ($)integer$ / sharesshares

Sep. 19, 2019USD ($)$ / sharesshares

Nov. 28, 2018USD ($)$ / sharesshares

Oct. 31, 2019USD ($)$ / sharesshares

Oct. 31, 2018USD ($)shares

Jul. 31, 2018USD ($)$ / sharesshares

Jul. 31, 2019USD ($)$ / sharesshares

Jul. 31, 2017shares

Apr. 03, 2016shares

Aug. 14, 2015shares

Aug. 10, 2015shares

Preferred stock, par value | $ / shares

$ 0.00001

Preferred stock, shares authorized

20,000,000

Preferred stock, shares issued

Common shares, par value | $ / shares

$ 0.00001

$ 0.00001

$ 0.00001

Common shares, authorized

6,000,000,000

6,000,000,000

6,000,000,000

Common stock, shares issued

2,845,318,757

2,622,904,757

2,845,318,757

Common shares, outstanding

2,845,318,757

2,622,904,757

2,845,318,757

Cost of goods sold | $

$ 32,193

Fair value of shares issued for services | $

$ 2,100

Common stock issued for services, Value | $

Common stock, value | $

28,453

$ 28,453

Amortization expense | $

$ 120,679

$ 3,300

Common stock option granted, shares

1,346,962,264

Yukun Qiu [Member] | Stock Options [Member]

Common stock option granted, shares

30,000,000

Stock options plan vesting description

vesting 33% each anniversary for three years.

Exercise Price | $ / shares

$ 0.0032

Stock option exercise period

3 years

Common stock option granted, value | $

$ 75,312

Maturity period

3 years 6 months

Stock volatility

244.00%

Share price | $ / shares

$ 0.0032

Expiration date

Dec. 11, 2022

Zhe Yan [Member] | Stock Options [Member]

Common stock option granted, shares

30,000,000

Stock options plan vesting description

vesting 33% each anniversary for three years.

Exercise Price | $ / shares

$ 0.0032

Stock option exercise period

3 years

Common stock option granted, value | $

$ 75,312

Maturity period

3 years 6 months

Stock volatility

244.00%

Share price | $ / shares

$ 0.0032

Expiration date

Dec. 11, 2022

Stock Option Plan [Member] | Su He [Member]

Common stock option granted, shares

30,000,000

Stock options plan vesting description

vesting 33% each anniversary for three years.

Exercise Price | $ / shares

$ 0.0011

Stock option exercise period

3 years

Common stock option granted, value | $

$ 29,869

Maturity period

3 years 6 months

Stock volatility

329.00%

Share price | $ / shares

$ 0.0011

Expiration date

May 29, 2022

Stock Option Plan [Member] | External Consultants (9) [Member]

Common stock option granted, shares

30,000,000

Stock options plan vesting description

vesting 33% each anniversary for three years.

Exercise Price | $ / shares

$ 0.0004

Stock option exercise period

3 years

Common stock option granted, value | $

$ 11,877

$ 71,260

Maturity period

3 years 6 months

Stock volatility

273.00%

Expiration date

Jun. 30, 2021

Number of consultants | integer

9

Stock option vested shares

60,000,000

Stock Option Plan [Member] | Chief Financial Officer [Member]

Common stock option granted, shares

105,000,000

210,000,000

Stock options plan vesting description

vesting 33% each half year.

vesting 33% each half year.

Exercise Price | $ / shares

$ 0.0055

$ 0.0004

Stock option exercise period

1 year 6 months

1 year 6 months

Common stock option granted, value | $

$ 332,446

$ 69,615

Maturity period

2 years

1 year

Stock volatility

111.00%

273.00%

Share price | $ / shares

$ 0.0055

$ 0.0004

Expiration date, description

the Company passed a board resolution to extend the expiration date from December 30, 2019 to June 30, 2020.

Stock Option Plan [Member] | Chief Executive Officer [Member]

Common stock option granted, shares

405,000,000

810,000,000

Stock options plan vesting description

vesting 33% each half year.

vesting 33% each half year for one and a half years.

Exercise Price | $ / shares

$ 0.00605

$ 0.00044

Stock option exercise period

1 year 6 months

1 year 6 months

Common stock option granted, value | $

$ 1,236,381

$ 265,821

Maturity period

2 years

1 year

Stock volatility

111.00%

273.00%

Share price | $ / shares

$ 0.0055

$ 0.0004

Expiration date, description

the Company passed a board resolution to extend the expiration date from December 30, 2019 to June 30, 2020.

Stock Option Plan [Member] | James Young [Member]

Common stock option granted, shares

210,000,000

Stock options plan vesting description

vesting 33% each anniversary for three years

Exercise Price | $ / shares

$ 0.0004

Stock option exercise period

3 years

Common stock option granted, value | $

$ 41,209

Maturity period

3 years 6 months

Stock volatility

263.00%

Share price | $ / shares

$ 0.0002

Expiration date

Jun. 30, 2021

Stock option vested shares

70,000,000

Stock Option Plan [Member] | Directors [Member]

Amortization expense | $

$ 120,679

Common stock option granted, shares

1,020,000,000

Stock Option Plan [Member] | Siu Kei Ho [Member]

Common stock option granted, shares

75,000,000

Exercise Price | $ / shares

$ 0.0004

Stock option exercise period

3 years

Expiration date

Jun. 30, 2021

Common stock option granted, value | $

Consulting Agreement [Member] | Hongfei Zhang [Member]

Common stock option granted, shares

30,000,000

Stock options plan vesting description

vesting 33% each anniversary for three years.

Exercise Price | $ / shares

$ 0.0008

Stock option exercise period

3 years

Common stock option granted, value | $

$ 22,056

Maturity period

3 years 6 months

Stock volatility

345.00%

Share price | $ / shares

$ 0.0008

Expiration date

Jun. 30, 2021

Stock option vested shares

10,000,000

Consulting Agreement [Member] | Michael Davies [Member] | Stock Options [Member]

Common stock option granted, shares

8,000,000

Stock options plan vesting description

P1Y

Exercise Price | $ / shares

$ 0.0022

Common stock option granted, value | $

$ 8,971

Maturity period

1 year

Stock volatility

136.00%

Share price | $ / shares

$ 0.0022

Expiration date

Apr. 9, 2020

Vesting period

Consulting Agreement [Member] | Marc Mcalister [Member] | Stock Options [Member]

Common stock option granted, shares

15,000,000

Stock options plan vesting description

the Company at exercise price of $0.0022 with vesting period of half year, vesting 100% on October 9, 2019.

Exercise Price | $ / shares

$ 0.0022

Common stock option granted, value | $

$ 16,820

Maturity period

1 year

Stock volatility

136.00%

Share price | $ / shares

$ 0.0022

Expiration date

Apr. 9, 2020

Vesting period

6 months

Series B Preferred Stock [Member]

Preferred stock, par value | $ / shares

$ 0.00001

$ 0.00001

Preferred stock, shares authorized

1,000

1,000

1,000

Preferred stock, shares issued

1,000

1,000

1,000

Percentage of preferred stock issued and outstanding, shares

100.00%

Preferred stock, shares outstanding

1,000

Preferred stock, shares cancelled

1,000

Series B Preferred Stock [Member] | Luxor Capital LLC [Member]

Preferred stock, shares issued

1,000

Series A Preferred Stock [Member]

Preferred stock, par value | $ / shares

$ 0.00001

$ 0.00001

Preferred stock, shares authorized

19,999,000

19,999,000

Preferred stock, shares issued

0

0

Preferred stock, shares outstanding

0

0

CONCENTRATIONS (Details Narrati

CONCENTRATIONS (Details Narrative)	3 Months Ended
	Oct. 31, 2019USD ($)integer	Oct. 31, 2018USD ($)
Revenues-related party	$ 519,569	$ 638,062
Accounts Receivable [Member]
Number of customers | integer	2
Accounts receivable - related parties	$ 1,070,300
Revenue [Member]
Number of customers | integer	2
Revenues-related party	$ 881,845
Articulate Pty Ltd [Member]
Concentration Risk, Percentage	86.00%
Cash received from customers	$ 931,500
Articulate Pty Ltd [Member] | Accounts Receivable [Member]
Concentration Risk, Percentage	44.00%
Articulate Pty Ltd [Member] | Revenue [Member]
Concentration Risk, Percentage	59.00%
Red Label Technology Pty Ltd [Member] | Accounts Receivable [Member]
Concentration Risk, Percentage	55.00%
Red Label Technology Pty Ltd [Member] | Revenue [Member]
Concentration Risk, Percentage	41.00%